Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2

NCT04405739 is registered in ClinicalTrials.gov with Ridgeback Biotherapeutics, LP as lead sponsor.

NCT NCT04405739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04405739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety of EIDD-2801 and Its Effect on Viral Shedding of SARS-CoV-2
Lead sponsor
Ridgeback Biotherapeutics, LP
Phase
Phase 2
Overall status
Completed
Start date
June 16, 2020
Completion date
February 21, 2022
Enrollment
71 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov 2